Skip to content

Opening book details…

About this Medicine article

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy by Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Domini (author);El-Sherbiny, Yasser (author);Rawstron, Andrew C. (author);Ponchel, Frederique (author);Emery, Paul (author);Buch, Maya H. (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Domini (author);El-Sherbiny, Yasser (author);Rawstron, Andrew C. (author);Ponchel, Frederique (author);Emery, Paul (author);Buch, Maya H. (author)
Publisher
BMJ Publishing Group
Published
2014
Field
Medicine (Health Sciences)

More by Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Domini (author);El-Sherbiny, Yasser (author);Rawstron, Andrew C. (author);Ponchel, Frederique (author);Emery, Paul (author);Buch, Maya H. (author)

Browse all works by Das, Sudipto (author);Vital, Edward M. (author);Horton, Sarah (author);Bryer, Domini (author);El-Sherbiny, Yasser (author);Rawstron, Andrew C. (author);Ponchel, Frederique (author);Emery, Paul (author);Buch, Maya H. (author)